Skip to main content
Erschienen in: Current Dermatology Reports 4/2021

19.11.2021 | Dermatology and its Use in Social Media (R Dellavalle and C Presley, Section Editors)

Social Media and Clinical Research in Dermatology

verfasst von: Ryan Geist, Michelle Militello, J. Mark Albrecht, Colby L. Presley, Jaclyn B. Anderson, Melissa Laughter, Chandler W. Rundle

Erschienen in: Current Dermatology Reports | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The immense growth of social media has afforded new opportunities in dermatology clinical research. This review serves to outline how social media has impacted clinical research and to explore future avenues for which social media can make a significant impact in dermatology clinical research.

Recent Findings

Recent clinical trials augmented by social media have demonstrated increased participant enrollment, shortened recruitment timelines, and decreased recruitment cost. The incorporation of social media into clinical research has also afforded greater access to teledermatology and the initiation of virtual clinical trials.

Summary

Clinical research serves as a primary source of evidence for refining healthcare practices by expanding the understanding of patient demographics, methods for improving patient care, and new therapeutic discoveries. Since its initiation, social media has played an integral and ever-expanding role in clinical research.
Literatur
3.
Zurück zum Zitat Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44:148–72.CrossRef Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, et al. Increasing diversity in clinical trials: overcoming critical barriers. Curr Probl Cardiol. 2019;44:148–72.CrossRef
4.
Zurück zum Zitat Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. Clin Trials Lond Engl. 2015;12:77–83.CrossRef Carlisle B, Kimmelman J, Ramsay T, MacKinnon N. Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. Clin Trials Lond Engl. 2015;12:77–83.CrossRef
5.
Zurück zum Zitat Bhardwaj SS, Camacho F, Derrow A, Fleischer AB Jr, Feldman SR. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. Arch Dermatol. 2004;140:1520–3.CrossRef Bhardwaj SS, Camacho F, Derrow A, Fleischer AB Jr, Feldman SR. Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. Arch Dermatol. 2004;140:1520–3.CrossRef
6.
Zurück zum Zitat Sedrak MS, Sun V, Liu J, George K, Wong AR, Dale W, et al. Physician perceptions of the use of social media for recruitment of patients in cancer clinical trials. JAMA Netw Open. 2019;2:e1911528.CrossRef Sedrak MS, Sun V, Liu J, George K, Wong AR, Dale W, et al. Physician perceptions of the use of social media for recruitment of patients in cancer clinical trials. JAMA Netw Open. 2019;2:e1911528.CrossRef
7.
Zurück zum Zitat Nguyen SH, Vu GT, Nguyen LH, Nguyen CT, Le THT, Tran TH, et al. Understanding social media use and engagement among dermatology patients to inform dermatological prevention and care in Vietnam: cross-sectional study. JMIR Dermatol. 2020;3:e13424.CrossRef Nguyen SH, Vu GT, Nguyen LH, Nguyen CT, Le THT, Tran TH, et al. Understanding social media use and engagement among dermatology patients to inform dermatological prevention and care in Vietnam: cross-sectional study. JMIR Dermatol. 2020;3:e13424.CrossRef
8.
Zurück zum Zitat Watson NL, Mull KE, Heffner JL, McClure JB, Bricker JB. Participant recruitment and retention in remote eHealth intervention trials: methods and lessons learned from a large randomized controlled trial of two web-based smoking interventions. J Med Internet Res. 2018;20:e10351.CrossRef Watson NL, Mull KE, Heffner JL, McClure JB, Bricker JB. Participant recruitment and retention in remote eHealth intervention trials: methods and lessons learned from a large randomized controlled trial of two web-based smoking interventions. J Med Internet Res. 2018;20:e10351.CrossRef
9.
Zurück zum Zitat Sedrak MS, Cohen RB, Merchant RM, Schapira MM. Cancer communication in the social media age. JAMA Oncol. 2016;2:822–3.CrossRef Sedrak MS, Cohen RB, Merchant RM, Schapira MM. Cancer communication in the social media age. JAMA Oncol. 2016;2:822–3.CrossRef
10.
Zurück zum Zitat Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, et al. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract. 2013;9:267–76.CrossRef Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, et al. The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations. J Oncol Pract. 2013;9:267–76.CrossRef
15.
Zurück zum Zitat •• Ali Z, Zibert JR, Thomsen SF. Virtual clinical trials: perspectives in dermatology. Dermatology. 2020;236:375–82. Describes the scope of various forms of digital media and remote communication currently utilized in dermatology and their potential significance in virtual clinical trials. •• Ali Z, Zibert JR, Thomsen SF. Virtual clinical trials: perspectives in dermatology. Dermatology. 2020;236:375–82. Describes the scope of various forms of digital media and remote communication currently utilized in dermatology and their potential significance in virtual clinical trials.
16.
Zurück zum Zitat • Laggis CW, Williams VL, Yang X, Kovarik CL. Research techniques made simple: teledermatology in clinical trials. J Invest Dermatol. 2019;139:1626-1633.e1. Elucidates the current role of teledermatology in the field of dermatology and the implications for its use in virtual clinical trials. • Laggis CW, Williams VL, Yang X, Kovarik CL. Research techniques made simple: teledermatology in clinical trials. J Invest Dermatol. 2019;139:1626-1633.e1. Elucidates the current role of teledermatology in the field of dermatology and the implications for its use in virtual clinical trials.
17.
Zurück zum Zitat • Desai S, Manjaly P, Lee KJ, Li SJ, Manjaly C, Mostaghimi A. The impact of COVID-19 on dermatology clinical trials. J Invest Dermatol. 2021;141:676–8. Demonstrates the impact of the Covid-19 pandemic on ongoing dermatologic clinical trials. • Desai S, Manjaly P, Lee KJ, Li SJ, Manjaly C, Mostaghimi A. The impact of COVID-19 on dermatology clinical trials. J Invest Dermatol. 2021;141:676–8. Demonstrates the impact of the Covid-19 pandemic on ongoing dermatologic clinical trials.
18.
Zurück zum Zitat • Sheriff T, Dickenson-Panas H, Murrell DF. Conducting dermatology clinical trials during the COVID-19 pandemic. Clin Dermatol. 2021;39:104–6. Outlines safety protocols and methods for minimizing risk when conducting dermatologic clinical trials during the Covid-19 pandemic. • Sheriff T, Dickenson-Panas H, Murrell DF. Conducting dermatology clinical trials during the COVID-19 pandemic. Clin Dermatol. 2021;39:104–6. Outlines safety protocols and methods for minimizing risk when conducting dermatologic clinical trials during the Covid-19 pandemic.
20.
Zurück zum Zitat Tate DF, LaRose JG, Griffin LP, Erickson KE, Robichaud EF, Perdue L, et al. Recruitment of young adults into a randomized controlled trial of weight gain prevention: message development, methods, and cost. Trials. 2014;15:326.CrossRef Tate DF, LaRose JG, Griffin LP, Erickson KE, Robichaud EF, Perdue L, et al. Recruitment of young adults into a randomized controlled trial of weight gain prevention: message development, methods, and cost. Trials. 2014;15:326.CrossRef
21.
Zurück zum Zitat Whitaker C, Stevelink S, Fear N. The use of Facebook in recruiting participants for health research purposes: a systematic review. J Med Internet Res. 2017;19:e290.CrossRef Whitaker C, Stevelink S, Fear N. The use of Facebook in recruiting participants for health research purposes: a systematic review. J Med Internet Res. 2017;19:e290.CrossRef
22.
Zurück zum Zitat • Ali SH, Foreman J, Capasso A, Jones AM, Tozan Y, DiClemente RJ. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20:116. Illustrates the utility of social media as a recruitment tool for clinical trials. • Ali SH, Foreman J, Capasso A, Jones AM, Tozan Y, DiClemente RJ. Social media as a recruitment platform for a nationwide online survey of COVID-19 knowledge, beliefs, and practices in the United States: methodology and feasibility analysis. BMC Med Res Methodol. 2020;20:116. Illustrates the utility of social media as a recruitment tool for clinical trials.
23.
Zurück zum Zitat Medina-Ramirez P, Calixte-Civil P, Meltzer LR, Brandon KO, Martinez U, Sutton SK, et al. Comparing methods of recruiting spanish-preferring smokers in the United States: findings from a randomized controlled trial. J Med Internet Res. 2020;22:e19389.CrossRef Medina-Ramirez P, Calixte-Civil P, Meltzer LR, Brandon KO, Martinez U, Sutton SK, et al. Comparing methods of recruiting spanish-preferring smokers in the United States: findings from a randomized controlled trial. J Med Internet Res. 2020;22:e19389.CrossRef
25.
Zurück zum Zitat Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA. 2020;323:844–53.CrossRef Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA. 2020;323:844–53.CrossRef
29.
Zurück zum Zitat Niyazov Y, Vogel C, Price R, Lund B, Judd D, Akil A, et al. Open access meets discoverability: citations to articles posted to Academia.edu. PLoS ONE. 2016;11:e0148257. Niyazov Y, Vogel C, Price R, Lund B, Judd D, Akil A, et al. Open access meets discoverability: citations to articles posted to Academia.edu. PLoS ONE. 2016;11:e0148257.
30.
Zurück zum Zitat Eysenbach G. Can tweets predict citations? Metrics of social impact based on Twitter and correlation with traditional metrics of scientific impact. J Med Internet Res. 2011;13:e123.CrossRef Eysenbach G. Can tweets predict citations? Metrics of social impact based on Twitter and correlation with traditional metrics of scientific impact. J Med Internet Res. 2011;13:e123.CrossRef
32.
Zurück zum Zitat Inan OT, Tenaerts P, Prindiville SA, Reynolds HR, Dizon DS, Cooper-Arnold K, et al. Digitizing clinical trials. Npj Digit Med Nature Publishing Group. 2020;3:1–7. Inan OT, Tenaerts P, Prindiville SA, Reynolds HR, Dizon DS, Cooper-Arnold K, et al. Digitizing clinical trials. Npj Digit Med Nature Publishing Group. 2020;3:1–7.
33.
Zurück zum Zitat Kosinski M, Matz SC, Gosling SD, Popov V, Stillwell D. Facebook as a research tool for the social sciences: opportunities, challenges, ethical considerations, and practical guidelines. Am Psychol. US: American Psychological Association; 20150907;70:543. Kosinski M, Matz SC, Gosling SD, Popov V, Stillwell D. Facebook as a research tool for the social sciences: opportunities, challenges, ethical considerations, and practical guidelines. Am Psychol. US: American Psychological Association; 20150907;70:543.
Metadaten
Titel
Social Media and Clinical Research in Dermatology
verfasst von
Ryan Geist
Michelle Militello
J. Mark Albrecht
Colby L. Presley
Jaclyn B. Anderson
Melissa Laughter
Chandler W. Rundle
Publikationsdatum
19.11.2021
Verlag
Springer US
Erschienen in
Current Dermatology Reports / Ausgabe 4/2021
Elektronische ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-021-00350-5

Weitere Artikel der Ausgabe 4/2021

Current Dermatology Reports 4/2021 Zur Ausgabe

Dermatology and its Use in Social Media (R Dellavalle and C Presley, Section Editors)

Social Media for Marketing and Business Promotion in Dermatology

Hospital-Based Dermatology (L Guggina and C Nguyen, Section Editors)

Updates and Insights in the Diagnosis and Management of DRESS Syndrome

Hospital-Based Dermatology (L Guggina and C Nguyen, Section Editors)

Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist

Hospital-Based Dermatology (L Guggina and C Nguyen, Section Editors)

Inpatient Management of Psoriasis: A Current Perspective and Update for Clinicians

Contact Dermatitis (Brandon Adler and Vincent Deleo, Section editors)

Patch Testing and Immunosuppression: a Comprehensive Review

Dermatology and its Use in Social Media (R Dellavalle and C Presley, Section Editors)

Social Media and Ethical Challenges for the Dermatologist

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.